- Home
- TXMD vs REFR Comparison
TXMD vs REFR Comparison
Compare TXMD & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXMD | REFR |
|---|---|---|
| Founded | 2008 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 20.9M |
| IPO Year | 2012 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TXMD | REFR |
|---|---|---|
| Price | $2.09 | $0.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 62.3K | 27.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.68 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,761,000.00 | $1,488,642.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $200.00 | ★ N/A |
| Revenue Growth | ★ 35.25 | N/A |
| 52 Week Low | $0.98 | $0.60 |
| 52 Week High | $2.95 | $2.70 |
Technical Indicators
Market Signals| Indicator | TXMD | REFR |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 29.33 |
| Support Level | $1.90 | N/A |
| Resistance Level | $2.16 | $0.83 |
| Average True Range (ATR) | 0.16 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 33.87 | 11.77 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.